Soluble urokinase plasminogen activator receptor associates with higher risk, advanced disease severity as well as inflammation, and might serve as a prognostic biomarker of severe acute pancreatitis

BACKGROUND: This study aimed to explore the potential of soluble urokinase plasminogen activator receptor (suPAR) as a biomarker for severe acute pancreatitis (SAP) risk prediction and disease management in SAP patients. METHODS: Totally 225 acute pancreatitis (AP) patients (including 75 SAP, 75 mod...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Qi, Li, Le, Chen, Hongze, Zhang, Guangquan, Zhu, Siqiang, Kong, Rui, Chen, Hua, Wang, Gang, Sun, Bei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7083411/
https://www.ncbi.nlm.nih.gov/pubmed/31774228
http://dx.doi.org/10.1002/jcla.23097

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7083411/
https://www.ncbi.nlm.nih.gov/pubmed/31774228
http://dx.doi.org/10.1002/jcla.23097

Ejemplares similares